| |
 Be a part of a dynamic medical team seeking advances in the treatment of chronic medical diseases. By participating, you can play a more active role in your healthcare, gain access to new research treatments before they are widely available, and help others by contributing to medical research.
Current trials are listed below. You can click on the trial name of interest to you and view the participant criteria information. If you would like us to contact you about a trial you will need to fill out the form for that trial. The form will be emailed directly to CEAGH. We will get back in touch with you.
We are currently seeking volunteers for the following clinical trials:
Diabetes Trial #1
| Participant Criteria: |
- Study evaluating the safety and effects of a new formulation of Insulin Glargine and Lantus in patients with Type 2 diabetes.
- Adults 18 years and older.
- Nine study visits during the 12 month trial duration.
- Must also be on mealtime insulin.
|
| If you meet the criteria for this trial and would like more information you can fill out the form below and click on the "Submit" button. |
| Or... call Gina Kavanaugh, RN, CCRP at 757-220-4751. |
|
|
Diabetes Trial #2
| Participant Criteria: |
- Study evaluating the safety and effects of a new formulation of Insulin Glargine and Lantus in patients with Type 2 diabetes.
- Adults 18 years and older.
- Nine study visits during the 12 month trial duration.
- Must be taking oral antihyperglycemic medication.
|
| If you meet the criteria for this trial and would like more information you can fill out the form below and click on the "Submit" button. |
| Or... call Gina Kavanaugh, RN, CCRP at 757-220-4751. |
|
|
C.Difficile Vaccine
| Participant Criteria: |
- Study evaluating the safety and effects of different formulations of a Clostridium difficile (C.diff) toxoid vaccine administered at three different schedules.
- Adults aged 40 to 75 years.
- Seven study visits during the 7 month trial duration.
- Must be at risk for developing C.diff infection because of impending hospitalization within 60 days of enrollment.
|
| If you meet the criteria for this trial and would like more information you can fill out the form below and click on the "Submit" button. |
| Or... call Gina Kavanaugh, RN, CCRP at 757-220-4751. |
|
|
Rheumatoid Arthritis
| Participant Criteria: |
- Study evaluating the safety and effects of two doses of MRC375 versus placebo in patients with moderate to severe RA.
- Adults 18 years or older.
- Eight study visits during the six month trial duration.
- Stable doses of current RA therapy excluding biologics and DMARDs which will require a washout period.
|
| If you meet the criteria for this trial and would like more information you can fill out the form below and click on the "Submit" button. |
| Or... call Gina Kavanaugh, RN, CCRP at 757-220-4751. |
|
|
Systemic Lupus Erythematosus (SLE)
| Participant Criteria: |
- Study evaluating the safety and effects of two injectable doses of LY2127399 versus placebo in patients with SLE.
- Adults 18 years or older.
- Sixteen study visits during the 12 month trial duration with the option of continuing in an open label extension after completion of the study.
|
| If you meet the criteria for this trial and would like more information you can fill out the form below and click on the "Submit" button. |
| Or... call Gina Kavanaugh, RN, CCRP at 757-220-4751. |
|
|
Alzheimer's Disease
| Participant Criteria: |
- Study evaluating the safety and effect on cognitive performance of three doses of SAR110894D versus placebo in patients with mild to moderate Alzheimer's Disease.
- Adults 55 years or older.
- Nine study visits during the 6 month trial duration.
- Must be on a stable dose of Aricept for at least 4 months and not be receiving any other medication for Alzheimer's Disease.
|
| If you meet the criteria for this trial and would like more information you can fill out the form below and click on the "Submit" button. |
| Or... call Gina Kavanaugh, RN, CCRP at 757-220-4751. |
|
|
Overactive Bladder
| Participant Criteria: |
- Study evaluating the effects of 8mg Fesoteroding compared to 4mg Fesoterodine versus placebo in patients with overactive bladder.
- Adults 18 years or older.
- Three study visits during the 3 month trial duration.
- Must rate their bladder problems as moderate to severe with episodes of urgency and incontinence.
|
| If you meet the criteria for this trial and would like more information you can fill out the form below and click on the "Submit" button. |
| Or... call Gina Kavanaugh, RN, CCRP at 757-220-4751. |
|
|
Participants in these clinical trials may be compensated for their time and travel.
If you do not meet the criteria for any current trials but would like information on participating in a future trial, please contact us. |
|
